REYATAZ

This page contains recent news articles, when available, and an overview of REYATAZ but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

The Hal Lewis Group Welcomes Four New Professionals  -  Sep 11, 2008
...industry’s highest awards and have successfully launched and promoted numerous premium health care brands, including Prinivil®, Coumadin®, and Reyataz®. PharmaLive.com (press release),

Norvir Label Updated With New Precaution  -  Sep 4, 2008
Bristol-Myers Squibb’s protease inhibitor Reyataz (atazanavir sulfate) — has not been evaluated for PR prolongation and needs to be done with caution, FDA news (subscription),

Idenix Pharma Completes Proof-Of-Concept Study for IDX899 - update  -  Sep 4, 2008
These separate studies were conducted using Reyataz and Truvada in combination with IDX899. The study drugs were well tolerated and there were no clinically RTT News,

Fitch Affirms Bristol-Myers Squibb Co.'s IDR at 'A+'; Outlook Stable  -  Sep 12, 2008
Operational success until this time will be driven by revenue gains of Bristol-Myers Squibb's five top-selling products: Plavix, Avapro, Abilify, Reyataz MarketWatch

Bristol-Myers Squibb Co. - From Hunted To Hunter....  -  Aug 25, 2008
Driven by double-digit sales growth of its key products namely Plavix, Reyataz, Sustiva and Abilify, and strong sales of its newer specialty and biologics RTT News,

Idenix Pharmaceuticals Announces Completion of Proof-of-Concept ...  -  Sep 4, 2008
These separate studies were conducted using Reyataz(R) and Truvada(R) in combination with IDX899 and concluded that the study drugs were well tolerated and Earthtimes (press release),

Glaxo's HIV-Drug Ads Draw Critics  -  Aug 24, 2008
Bristol-Myers' antiviral drug Reyataz isn't commonly associated with diarrhea. Brian Henry, a spokesman for Bristol-Myers, said the ad is appropriate. Wall Street Journal

GlaxoSmithKline drug ad sparks a debate  -  Aug 28, 2008
Bristol-Myers' antiviral drug Reyataz is believed to be less likely than other drugs to cause that side effect. GlaxoSmithKline, an early leader in HIV Philadelphia Inquirer,

Bristol-Myers Squibb Co. - From Hunted To Hunter....  -  Aug 25, 2008
The company's key products include blood thinner drug Plavix, anti-hypertension drugs Avapro/Avalide, HIV drugs Reyataz and Sustiva, antipsychotic drug RTT News,

Alerta VIH  -  Sep 14, 2008
Nos informan que en la farmacia del IVSS de Guaraguao, Puerto la Cruz, no hay Reyataz ni Duovir desde hace varios días. A los usuarios les dicen que "desde El Universal (Venezuela),

Bristol-Myers se recupera después de pasar un mal año  -  Sep 1, 2008
Otros productos destacados fueron Abilify (desórdenes bipolares), Sustiva y Reyataz (ambos destinados a combatir el sida), así como Baraclude (hepatitis B). El Global,

아보트, �?�?�즈 Norvir 주�?�표시 강화  -  Sep 7, 2008
...�?� 새로운 주�?� 표시�?는 연질 캅셀, 경구 용액제 모�?�? �?용�?�며 기타 �?�약품과 �?�?�즈 약�?� 병용 투여는 즉, BMS�?� Reyataz(atazanavir sulfate)를 �?�함한 PR 간격 메디�?�뉴스,

Reyataz : extension d’AMM  -  Aug 19, 2008
Enfin libres! vous venez d'emménager dans votre 1er appart (chambre de bonne, studio, cité U, coloc)! Racontez-nous votre nouvelle vie ! TÊTU,

Going-Concern Statement  -  Aug 6, 2008
Overall in the CASTLE study, 78 percent of the 440 patients in the REYATAZ(R) (atazanavir sulfate)/r arm and 76 percent of the 443 patients in the FOXBusiness

Atazanavir (Reyataz) Meets Standard for Initial HIV Therapy  -  Aug 1, 2008
1 -- In HIV patients just starting therapy, the protease inhibitor atazanavir (Reyataz), boosted with ritonavir, is a good first-line treatment option, MedPage Today,

FDA Safety Changes: Reyataz and Invanz  -  Jul 30, 2008
On March 26, the FDA approved safety labeling revisions for atazanavir sulfate capsules (Reyataz; Bristol-Myers Squibb Company) to advise of important drug Medscape (subscription)

IAC: Unboosted Atazanavir HIV Regimen Found Inferior  -  Aug 8, 2008
The combination tested was didanosine (Videx), emtricitabine (Emtriva), and atazanavir (Reyataz), all taken once a day, according to Thomas Campbell, MD, MedPage Today,

Bristol-Myers Squibb reveals gender-based HIV drug data  -  Aug 6, 2008
Bristol-Myers Squibb says trial data has shown that its HIV drug Reyataz achieved similar levels of success in men and women. The study, which involved 277 Hays Pharma,

Bristol-Myers Squibb reveals results from pre-specified ...  -  Aug 5, 2008
CASTLE is the first large-scale, open-label, randomized study designed to demonstrate the non-inferiority of REYATAZ/r to lopinavir/r in previously RTT News,

Cost-cutting helps B-MS profits and more cuts are planned  -  Jul 25, 2008
Sales of its Sustiva (efavirenz) franchise rose 21% to $282 million and Reyataz (atazanavir) was up 28% to $324 million. The cancer agent Erbitux Pharma Times (subscription),

Bristol Profit Beats Forecasts, Helped by Plavix  -  Jul 24, 2008
Sales of HIV treatment Reyataz, helped by its convenient once-daily dosing, surged 28 percent to $324 million, while sales of cancer drug Erbitux rose 21 CNBC,

BRIEF: Biotis gets Bristol-Myers distribution deal: Biotis will ...  -  Jul 22, 2008
The drugs are Baraclude for hepatitis B, Ixempra for early-stage breast cancer, Orcencia for rheumatoid arthritis, Reyataz for AIDS, and Sprycel for Trading Markets (press release),

How does abacavir/3TC compare to tenofovir/FTC? ACTG5202 and GSK ...  -  Aug 7, 2008
Group (ACTG) Study A5202, each of these two nucleoside pairs has been paired with either efavirenz (Sustiva) or ritonavir-boosted atazanavir (Reyataz). Aidsmap,

Switch to atazanavir does not reduce belly fat  -  Aug 4, 2008
...determine whether switching from a ritonavir-boosted protease inhibitor to atazanavir/ritonavir (Reyataz) would reduce fat accumulation in the abdomen. Aidsmap,

IAC: HIV Care Guidelines Expand Treatment Eligibility  -  Aug 3, 2008
The preferred NNRTI is efavirenz (Sustiva), but several PIs are suggested, including lopinavir (Kaletra), atazanavir (Reyataz), fosamprenavir (Lexiva), MedPage Today,

Bristol-Myers Squibb Co. Q2 2008 Earnings Call Transcript  -  Jul 27, 2008
Turning to virology, Reyataz was up 28% globally including 13% US TRx growth. SUSTIVA Franchise, sales were up by 21% globally behind the strong performance Seeking Alpha,

Gilead now testing ritonavir replacement in human studies  -  Jul 23, 2008
Coformulation deals with other companies could follow, with Bristol Myers-Squibb’s atazananvir (Reyataz) an obvious candidate. A second or third-line fixed Aidsmap,

Market Report -- In Play (BMY)  -  Aug 5, 2008
Bristol-Myers announces CASTLE data showed boosted REYATAZ and Lopinavir/r achieved similar results for undetectable viral load in treatment-naive HIV-1 MSN Money

Prohiben papel de aluminio, marca Pro- Luminio y Reyataz ...  -  Jul 25, 2008
Envases y equipamiento en contacto directo con alimentos. Prohíbese la comercialización del producto “Papel de Aluminio, marca Pro- Luminio, fabricado por Misionlandia,

Una pastilla menos para la infección por VIH  -  Aug 1, 2008
El estudio concluye que atazanavir –comercializado en España como Reyataz por Bristol Myers Squibb– es igual de eficaz que lopinavir y lo recomiendan como Público,

施贵�?第二季度盈利�?�比攀�?�8.2%  -  Jul 24, 2008
...精神病�?�Abilify销售�?激增25%，至5.29亿美元；HIV治疗�?�Reyataz 新浪网,

Actu des traitements  -  Jul 31, 2008
Le Reyataz® est utilisé à 300 mg, boosté par du Norvir® dosé à 100 mg, en une prise par jour. Depuis quelques semaines nous avons à nouveau des échos Act Up-Paris,

制�?�六巨头第二财季盈利四�?�两�?  -  Jul 24, 2008
...得益于Plavix�?Abilify和Reyataz 慧�?�网,

Atazanavir, nueva opción en pacientes no tratados  -  Jul 13, 2008
Se trata de una nueva indicación para atazanavir (Reyataz), que se utiliza en dosis de 300 mg una vez al día, potenciado con ritonavir (100 mg una vez al Correo Farmacéutico,

Weak US dollar should boost Big Pharma earnings  -  Jul 20, 2008
Cowen sees solid double-digit growth for several of Bristol-Myers newer products, including Abilify, Reyataz, Orencia and Sprycel. Middle East North Africa Financial Network,

FOKUS 1-Gewinnanstieg beim US-Pharmakonzern Bristol-Myers Squibb  -  Jul 24, 2008
Das Aids-Präparat Reyataz brachte es auf Erlöse von 324 Millionen Dollar, was einem Zuwachs von 28 Prozent entspricht. Das Schizophreniemittel Abilify fuhr Reuters Deutschland,

Bristol-Myers Squibb (BMS): hausse du résultat 2T, nouveau plan d ...  -  Jul 24, 2008
La progression est de 21% pour le traitement contre le cancer colorectal Erbitux, à 196 millions, et de 28% pour le traitement anti-sida Reyataz, L'Agefi (Abonnement),

Wall Street : dans le rouge après les chiffres du logement  -  Jul 24, 2008
Reyataz progresse de 28% à 324 M$ et Abilify de 28% aussi, à 529 M$. Le bénéfice net des opérations continues a été de 722 M$ et 36 cents par titre, Boursier.com,

Espoirs en résistance majeure  -  Jul 31, 2008
Kaletra® (lopinavir/ritonavir), Norvir® (ritonavir), Prezista® (darunavir), Reyataz® (atazanavir), Telzir® (fosamprénavir), Viracept® (nelfinavir). Act Up-Paris,

百時美-施貴寶第二季度盈利�?�比攀�?�8.2%  -  Jul 24, 2008
...精神病藥Abilify銷售�?激增25%，至5.29億美元；HIV治療藥Reyataz 新浪網,

Bristol-Myers Squibb : merci le Plavix !  -  Jul 24, 2008
Reyataz progresse de 28% à 324 M$ et Abilify de 28% aussi, à 529 M$. Le bénéfice net des opérations continues a été de 722 M$ et 36 cents par titre, Boursier.com,

Driven By The Use of Premium-Priced Branded Agents, The HIV Drug ...  -  02 Jun 2008
..."The increasingly wider use of premium-priced marketed products such as Atripla, Truvada, and Reyataz in early lines of therapy will be the major growth Earthtimes (press release),

Once-Daily HIV Medicine Reyataz(R) (atazanavir) Now Available In ...  -  May 8, 2008
Reyataz® (atazanavir), the only protease inhibitor approved in the UK for once-daily dosing, is now available as a single 300mg capsule. Medical News Today (press release),

Low rate of toxicity-related treatment change suggests HIV ...  -  May 28, 2008
The study found that some anti-HIV treatment combinations, for example those including tenofovir (Viread), efavirenz (Sustiva) or atazanavir (Reyataz) were Aidsmap,

The Hal Lewis Group Announces One Promotion  -  May 20, 2008
...industry’s highest awards, and have successfully launched and promoted numerous premium healthcare brands, including Prinivil®, Coumadin®, and Reyataz®. PharmaLive.com (press release),

Insulin resistance may predict risk of cardiovascular disease in HIV  -  May 7, 2008
In their study, 76% of people taking a protease inhibitor-based regimen were taking ritonavir-boosted atazanavir (Reyataz), one of the newest anti-HIV drugs Aidsmap,

Traces of Drugs Found in Drinking Water  -  May 6, 2008
OxyContin tablets (oxycodone), Avinza capsules (morphine sulfate), Baraclude tablets (entecavir), Reyataz capsules (atazanavir sulfate), Tequin tablets Journal of American Medical Association (subscription),

ROCKVILLE, Md., March 26, 2008--The Reyataz (atazanavir) Capsule ...  -  Mar 26, 2008
REYATAZ should not be administered to pediatric patients below the age of 3 months due to the risk of kernicterus (a type of brain damage caused by PharmaLive.com (press release),

The Hal Lewis Group Announces New Executive Creative Director  -  Apr 17, 2008
...industry’s highest awards, and have successfully launched and promoted numerous premium healthcare brands, including Prinivil®, Coumadin®, and Reyataz®. PharmaLive.com (press release),

The Hal Lewis Group Announces One Promotion.  -  Apr 8, 2008
...industry’s highest awards and have successfully launched and promoted numerous premium health care brands, including Prinivil, Coumadin, and Reyataz. PharmaLive.com (press release),

FDA updates atazanavir prescribing information for kids  -  Mar 28, 2008
Drug regulatory authorities in the US have issued revised dosing recommendations for the use of the protease inhibitor atazanavir (Reyataz) in children. Aidsmap,

Heavyweights Fall Hard  -  Apr 1, 2008
...tetanus, and pertussis, Adacel; Bristol-Myers Squibb's HIV therapy, Reyataz, and Janssen's Risperdal, for schizophrenia and bipolar disorder. Medical Marketing and Media,

Drugs In Our Drinking Water? How To Dispose of Your Medications Safely  -  12 Mar 2008
...the attention deficit-hyperactivity disorder drug methylphenidate (Daytrana Transdermal Patch); and the HIV drugs atazanavir (Reyataz) and stavudine PR Web (press release),

Castle Study Shows Boosted Reyataz(R) (Atazanavir) Is A Well ...  -  Feb 13, 2008
The week-48 results of the CASTLE study were announced at the 15th Conference on Retroviruses and Opportunistic Infections (CROI) and showed boosted Medical News Today (press release),

Concerns in US study over abacavir/3TC's potency in patients with ...  -  Feb 29, 2008
...plus atazanavir (Reyataz) boosted by ritonavir (Norvir), or tenofovir/FTC (Truvada) plus efavirenz, or tenofovir/FTC plus atazanavir/ritonavir. Aidsmap,

FDA approves generic atazanavir  -  Feb 13, 2008
The originator version of atazanavir, marketed as Reyataz, is manufactured by Bristol Myers Squibb. The company issued voluntary licenses to manufacture Aidsmap,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.